Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10805)
All Articles published online
|
Publishing Process of This Article
|
Apr 21, 2017 (publication date) through Jul 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Portillo I, Arana-Arri E, Idigoras I, Bilbao I, Martínez-Indart L, Bujanda L, Gutierrez-Ibarluzea I. Colorectal and interval cancers of the Colorectal Cancer Screening Program in the Basque Country (Spain). World J Gastroenterol 2017; 23(15): 2731-2742 [PMID: 28487610 DOI: 10.3748/wjg.v23.i15.2731] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i15/2731.htm |
| Number | Citing Articles |
| 1 |
Manuel Zorzi, Cesare Hassan, Carlo Senore, Giulia Capodaglio, Anna Turrin, Elena Narne, Alessio Mussato, Silvia Rizzato, Enrico Chinellato, Sara Zamberlan, Alessandro Repici, Massimo Rugge. Interval colorectal cancers after negative faecal immunochemical test in a 13-year screening programme. Journal of Medical Screening 2021; 28(2): 131 doi: 10.1177/0969141320918613
|
| 2 |
Manuel Zorzi, Nicola Gennaro, Giulia Capodaglio, Emanuele Damiano Luca Urso, Salvatore Pucciarelli, Laura Memo, Eva Carpin, Mariachiara Corti, Massimo Rugge, Ugo Fedeli. Colorectal cancer screening: The surgery rates they are a-changing. A nationwide study on surgical resections in Italy. Digestive and Liver Disease 2019; 51(2): 304 doi: 10.1016/j.dld.2018.10.011
|
| 3 |
Wei-miao Wu, Yingying Wang, Hui-ru Jiang, Chen Yang, Xiao-qiang Li, Bei Yan, Yi Zhou, Wang-hong Xu, Tao Lin. Colorectal Cancer Screening Modalities in Chinese Population: Practice and Lessons in Pudong New Area of Shanghai, China. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00399
|
| 4 |
Andrea Buron, Marta Román, Josep M. Augé, Francesc Macià, Jaume Grau, Maria Sala, Javier Louro, Montserrat Martinez-Alonso, Cristina Alvarez-Urturi, Montserrat Andreu, Xavier Bessa, Diana Zaffalon, Antoni Castells, Maria Pellisé, Marta Aldea, Liseth Rivero, Cristina Hernández, Isabel Torá-Rocamora, Xavier Castells. Changes in FIT values below the threshold of positivity and short-term risk of advanced colorectal neoplasia: Results from a population-based cancer screening program. European Journal of Cancer 2019; 107: 53 doi: 10.1016/j.ejca.2018.11.004
|
| 5 |
Jakub Świtalski, Tomasz Tatara, Katarzyna Wnuk, Wojciech Miazga, Dagmara Karauda, Adrian Matera, Magdalena Jabłońska, Sylwia Jopek, Urszula Religioni, Mariusz Gujski. Clinical Effectiveness of Faecal Immunochemical Test in the Early Detection of Colorectal Cancer—An Umbrella Review. Cancers 2022; 14(18): 4391 doi: 10.3390/cancers14184391
|
| 6 |
Isabel Portillo, Isabel Idigoras, Isabel Bilbao, Eunate Arana-Arri, María José Fernández-Landa, Jose Luis Hurtado, Cristina Sarasaqueta, Luis Bujanda. Colorectal cancer screening program using FIT: quality of colonoscopy varies according to hospital type. Endoscopy International Open 2018; 6(09): E1149 doi: 10.1055/a-0655-1987
|
| 7 |
Future Prospects of Colorectal Cancer Screening: Characterizing Interval Cancers. Cancers 2021; 13(6): 1328 doi: 10.3390/cancers13061328
|
| 8 |
Joaquín Cubiella, Antía González, Raquel Almazán, Elena Rodríguez-Camacho, Juana Fontenla Rodiles, Carmen Domínguez Ferreiro, Coral Tejido Sandoval, Cristina Sánchez Gómez, Natalia de Vicente Bielza, Isabel Lorenzo, Raquel Zubizarreta. pT1 Colorectal Cancer Detected in a Colorectal Cancer Mass Screening Program: Treatment and Factors Associated with Residual and Extraluminal Disease. Cancers 2020; 12(9): 2530 doi: 10.3390/cancers12092530
|
| 9 |
Thuy Ngan Tran, Marc Peeters, Sarah Hoeck, Guido Van Hal, Sharon Janssens, Harlinde De Schutter. Optimizing the colorectal cancer screening programme using faecal immunochemical test (FIT) in Flanders, Belgium from the “interval cancer” perspective. British Journal of Cancer 2022; 126(7): 1091 doi: 10.1038/s41416-021-01694-2
|
| 10 |
Esther Toes-Zoutendijk, Arthur I. Kooyker, Evelien Dekker, Manon C.W. Spaander, Annemieke W.J. Opstal-van Winden, Christian Ramakers, Maaike Buskermolen, Anneke J. van Vuuren, Ernst J. Kuipers, Folkert J. van Kemenade, Marie-Louise F. Velthuysen, Maarten G.J. Thomeer, Harriët van Veldhuizen, Marjolein van Ballegooijen, Iris D. Nagtegaal, Harry J. de Koning, Monique E. van Leerdam, Iris Lansdorp-Vogelaar, A. van der Beek, J.A. Otte, Tj. Wiersma, A.A.M. Masclee, J. van Bergeijk, G. Meijer, E.J.R. de Graaf, W.M.U. van Grevenstein, M. Frasa, L.H.J. Jacobs, J. Stoker, G. Vink, M.A. Elferink. Incidence of Interval Colorectal Cancer After Negative Results From First-Round Fecal Immunochemical Screening Tests, by Cutoff Value and Participant Sex and Age. Clinical Gastroenterology and Hepatology 2020; 18(7): 1493 doi: 10.1016/j.cgh.2019.08.021
|
| 11 |
Carole Vitellius, Margot Laly, Anne-Sophie Banaszuk, Isabelle Deherce, Nathanaëlle Cornet, Sandrine Bertrais, Patrick Saulnier, François-Xavier Caroli-Bosc. Contribution of the OC Sensor® immunoassay in comparison to the Hemoccult II® guaiac-test in organized colorectal cancer screening. European Journal of Epidemiology 2019; 34(2): 163 doi: 10.1007/s10654-018-0471-z
|
| 12 |
Isabel Idigoras Rubio, Eunate Arana-Arri, Isabel Portillo Villares, Isabel Bilbao Iturribarrria, Lorea Martínez-Indart, Natale Imaz-Ayo, Marta de la Cruz, Visitación de Castro, Arantza López de Munain, Idoia Torrejón Perez, Iñaki Gutiérrez-Ibarluzea. Participation in a population-based screening for colorectal cancer using the faecal immunochemical test decreases mortality in 5 years. European Journal of Gastroenterology & Hepatology 2019; 31(2): 197 doi: 10.1097/MEG.0000000000001338
|
| 13 |
Jia-Yi Hou, Ning Li, Jie Wang, Li-Juan Gao, Jia-Song Chang, Ji-Min Cao. Histone crotonylation of peripheral blood mononuclear cells is a potential biomarker for diagnosis of colorectal cancer. Epigenetics & Chromatin 2023; 16(1) doi: 10.1186/s13072-023-00509-3
|
| 14 |
Mercedes Vanaclocha-Espí, Marina Pinto-Carbó, Josefa Ibáñez, María José Valverde-Roig, Isabel Portillo, Francisco Pérez-Riquelme, Mariola de la Vega, Susana Castán-Cameo, Dolores Salas, Ana Molina-Barceló. Interval Cancer in Population-Based Colorectal Screening Programmes: Incidence and Characteristics of Tumours. Cancers 2024; 16(4): 769 doi: 10.3390/cancers16040769
|
| 15 |
Els Wieten, Eline H Schreuders, Esmée J Grobbee, Daan Nieboer, Wichor M Bramer, Iris Lansdorp-Vogelaar, Marco J Bruno, Ernst J Kuipers, Manon C W Spaander. Incidence of faecal occult blood test interval cancers in population-based colorectal cancer screening: a systematic review and meta-analysis. Gut 2019; 68(5): 873 doi: 10.1136/gutjnl-2017-315340
|
| 16 |
Saloa Unanue-Arza, Isabel Idigoras-Rubio, Maria Jose Fernández-Landa, Isabel Bilbao-Iturribarria, Luis Bujanda, Isabel Portillo. Analysis of Post-Colonoscopy Colorectal Cancer and Its Subtypes in a Screening Programme. Cancers 2021; 13(20): 5105 doi: 10.3390/cancers13205105
|
| 17 |
Andrea Burón, Francesc Macià, Montserrat Andreu, Maria Pellisé, Xavier Castells, Jaume Grau. Population-based colorectal cancer screening: Interval cancers and relationship with the quantitative faecal immunological for hemoglobin. Medicina Clínica (English Edition) 2019; 152(8): 303 doi: 10.1016/j.medcle.2019.02.005
|
| 18 |
Rachel Gingold-Belfer, Haim Leibovitzh, Doron Boltin, Nidal Issa, Tsachi Tsadok Perets, Ram Dickman, Yaron Niv. The compliance rate for the second diagnostic evaluation after a positive fecal occult blood test: A systematic review and meta‐analysis. United European Gastroenterology Journal 2019; 7(3): 424 doi: 10.1177/2050640619828185
|
| 19 |
Manuel Zorzi, Giulia Capodaglio, Massimo Rugge. Interval Cancers in Colorectal Cancer Screening Programs. Gastroenterology 2018; 154(3): 762 doi: 10.1053/j.gastro.2017.09.051
|
| 20 |
Kai Sheng Saw, Kerry Sexton, Paul Frankish, Mike Hulme-Moir, Ian Bissett, Susan Parry. Interval colorectal cancers after negative faecal immunochemical test in the New Zealand Bowel Screening Pilot. BMJ Open Gastroenterology 2023; 10(1): e001233 doi: 10.1136/bmjgast-2023-001233
|
| 21 |
Sara Ramos Lopes, Claudio Martins, Inês Costa Santos, Madalena Teixeira, Élia Gamito, Ana Luisa Alves. Colorectal cancer screening: A review of current knowledge and progress in research. World Journal of Gastrointestinal Oncology 2024; 16(4): 1119-1133 doi: 10.4251/wjgo.v16.i4.1119
|
| 22 |
Dominika Novak Mlakar, Tatjana Kofol Bric, Ana Lucija Škrjanec, Mateja Krajc. Interval cancers after negative immunochemical test compared to screen and non-responders’ detected cancers in Slovenian colorectal cancer screening programme. Radiology and Oncology 2018; 52(4): 413 doi: 10.2478/raon-2018-0025
|
| 23 |
Ana Isabel Cobo-Cuenca, José Alberto Laredo-Aguilera, María-Aurora Rodríguez-Borrego, Esmeralda Santacruz-Salas, Juan Manuel Carmona-Torres. Temporal Trends in Fecal Occult Blood Test: Associated Factors (2009–2017). International Journal of Environmental Research and Public Health 2019; 16(12): 2120 doi: 10.3390/ijerph16122120
|
| 24 |
Eline H Schreuders, Esmée J Grobbee, Stella A V Nieuwenburg, Atija Kapidzic, Aafke H C van Roon, Anneke J van Vuuren, Iris Lansdorp-Vogelaar, Wolfert W J Spijker, Kirsten Izelaar, Marco J Bruno, Ernst J Kuipers, Manon C W Spaander. Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study. The Lancet Gastroenterology & Hepatology 2019; 4(8): 622 doi: 10.1016/S2468-1253(19)30176-1
|
| 25 |
Oiana Telleria, Oihane E. Alboniga, Marc Clos-Garcia, Beatriz Nafría-Jimenez, Joaquin Cubiella, Luis Bujanda, Juan Manuel Falcón-Pérez. A Comprehensive Metabolomics Analysis of Fecal Samples from Advanced Adenoma and Colorectal Cancer Patients. Metabolites 2022; 12(6): 550 doi: 10.3390/metabo12060550
|
| 26 |
Andrea Burón, Francesc Macià, Montserrat Andreu, Maria Pellisé, Xavier Castells, Jaume Grau. Cribado poblacional de cáncer colorrectal: cánceres de intervalo y relación con el resultado cuantitativo del test inmunológico de sangre oculta en heces. Medicina Clínica 2019; 152(8): 303 doi: 10.1016/j.medcli.2018.06.022
|
| 27 |
Wessel van de Veerdonk, Sarah Hoeck, Marc Peeters, Guido Van Hal, Julie Francart, Isabel De Brabander. Occurrence and characteristics of faecal immunochemical screen‐detected cancers vs non–screen‐detected cancers: Results from a Flemish colorectal cancer screening programme. United European Gastroenterology Journal 2020; 8(2): 185 doi: 10.1177/2050640619882157
|
| 28 |
Aasma Shaukat, Theodore R. Levin. Current and future colorectal cancer screening strategies. Nature Reviews Gastroenterology & Hepatology 2022; 19(8): 521 doi: 10.1038/s41575-022-00612-y
|
| 29 |
UEG Week 2018 Poster Presentations. United European Gastroenterology Journal 2018; 6(S8) doi: 10.1177/2050640618792819
|
| 30 |
Masau Sekiguchi, Yoshihiro Kishida, Hiroaki Ikematsu, Maki Konno, Yasuhiko Mizuguchi, Kinichi Hotta, Kenichiro Imai, Sayo Ito, Kazunori Takada, Akio Shiomi, Hirofumi Yasui, Shunsuke Tsukamoto, Hidekazu Hirano, Nozomu Kobayashi, Yutaka Saito, Atsushi Inaba, Kensuke Shinmura, Jun Konishi, Heita Ozawa, Shin Fujita, Yoshitaka Murakami, Takahisa Matsuda. Proportions and characteristics of interval cancer in annual fecal immunochemical test screening and postcolonoscopy colorectal cancer: Results from a Japanese multicenter prospective study using questionnaires, the C‐DETECT study. Digestive Endoscopy 2024; doi: 10.1111/den.14772
|